Article
Abnormal serotonergic development in a mouse model for the Smith-Lemli-Opitz syndrome: implications for autism.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience - 1 Dec 2003
Waage-Baudet H, Lauder J M, Dehart D B, Kluckman K, Hiller S, Tint G S, Sulik K K
Abstract excerpt
The Smith-Lemli-Opitz syndrome (SLOS) is a malformation/mental retardation syndrome resulting from an inborn error in 3beta-hydroxysteroid Delta7-reductase (DHCR7), the terminal enzyme required for cholesterol biosynthesis. Using a targeting strategy designed to virtually eliminate Dhcr7 activity, we have created a SLOS mouse model that exhibits commissural deficiencies, hippocampal abnormalities, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
